Functional validation and expression analysis of myotubes converted from skin fibroblasts using a simple direct reprogramming strategy

Fujii, 2006, Adenoviral mediated MyoD gene transfer into fibroblasts: myogenic disease diagnosis, Brain and Development, 28, 420, 10.1016/j.braindev.2005.12.007 Davis, 1987, Expression of a single transfected cDNA converts fibroblasts to myoblasts, Cell, 51, 987, 10.1016/0092-8674(87)90585-X Goudenege, 2012, Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation, Mol. Ther., 20, 2153, 10.1038/mt.2012.188 Kanegae, 1994, A simple and efficient method for purification of infectious recombinant adenovirus, Jpn. J. Med. Sci. Biol., 47, 157, 10.7883/yoken1952.47.157 Manabe, 2012, Characterization of an acute muscle contraction model using cultured C2C12 myotubes, PLoS One, 7, 10.1371/journal.pone.0052592 Tanaka, 2013, Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro, PLoS One, 8, 10.1371/journal.pone.0061540 Tai, 2011, Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer, Skelet. Muscle, 1, 25, 10.1186/2044-5040-1-25 Trapecar, 2014, Myogenic progenitors and imaging single-cell flow analysis: a model to study commitment of adult muscle stem cells, J. Muscle Res. Cell Motil., 35, 249, 10.1007/s10974-014-9398-5 Kuang, 2008, The emerging biology of satellite cells and their therapeutic potential, Trends Mol. Med., 14, 82, 10.1016/j.molmed.2007.12.004 Miller, 1990, Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms, MyoD1, and myogenin, J. Cell Biol., 111, 1149, 10.1083/jcb.111.3.1149 Hoffman, 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4 Blake, 2002, Function and genetics of dystrophin and dystrophin-related proteins in muscle, Physiol. Rev., 82, 291, 10.1152/physrev.00028.2001 James, 1993, Dystrophin and membrane skeleton, Curr. Opin. Cell Biol., 5, 82, 10.1016/S0955-0674(05)80012-2 Millay, 2013, Myomaker is a membrane activator of myoblast fusion and muscle formation, Nature, 499, 301, 10.1038/nature12343 Fakhfakh, 2012, Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice, Cell Transplant., 21, 1419, 10.3727/096368911X627480 Zeng, 2014, The ryanodine receptor agonist 4-chloro-3-ethylphenol blocks ORAI store-operated channels, Br. J. Pharmacol., 171, 1250, 10.1111/bph.12528 Buvinic, 2009, ATP released by electrical stimuli elicits calcium transients and gene expression in skeletal muscle, J. Biol. Chem., 284, 34490, 10.1074/jbc.M109.057315 Jacobson, 2006, Structural determinants of 4-chloro-m-cresol required for activation of ryanodine receptor type 1, Mol. Pharmacol., 70, 259, 10.1124/mol.106.022491 Westerblad, 1998, Effects of ryanodine receptor agonist 4-chloro-m-cresol on myoplasmic free Ca2+ concentration and force of contraction in mouse skeletal muscle, Cell Calcium, 24, 105, 10.1016/S0143-4160(98)90078-1 Leriche-Guerin, 2002, Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice, Neuromuscul. Disord., 12, 167, 10.1016/S0960-8966(01)00254-1 Peault, 2007, Stem and progenitor cells in skeletal muscle development, maintenance, and therapy, Mol. Ther., 15, 867, 10.1038/mt.sj.6300145 Benabdallah, 2008, Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice, Cell Transplant., 17, 337, 10.3727/096368908784153913 Wakabayashi, 2015, Mechanism of the calcium-regulation of muscle contraction—in pursuit of its structural basis, Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 91, 321, 10.2183/pjab.91.321 Mylona, 2006, CD44 regulates myoblast migration and differentiation, J. Cell. Physiol., 209, 314, 10.1002/jcp.20724 Jansen, 2006, Mannose receptor regulates myoblast motility and muscle growth, J. Cell Biol., 174, 403, 10.1083/jcb.200601102